Cytokinetics Inc (CYTK)
51.81
-0.13
(-0.25%)
USD |
NASDAQ |
Jun 20, 16:00
51.81
0.00 (0.00%)
After-Hours: 20:00
Cytokinetics Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2009 | 39.84M |
| December 31, 2008 | 53.95M |
| December 31, 2007 | 53.39M |
| December 31, 2006 | 49.22M |
| December 31, 2005 | 40.57M |
| Date | Value |
|---|---|
| December 31, 2004 | 39.88M |
| December 31, 2003 | 34.20M |
| December 31, 2002 | 28.42M |
| December 31, 2001 | 20.96M |
| December 31, 2000 | 10.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen Inc | 4.784B |
| Johnson & Johnson | 15.08B |
| Eli Lilly and Co | 9.313B |
| Madrigal Pharmaceuticals Inc | 272.35M |
| Viking Therapeutics Inc | 63.81M |